Gardasil 9 syringe 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F3FU8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $36,615
Award facts
- Contract value 100% obligated
- $36,614.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $36,614.93 to AmerisourceBergen Drug Corp for the supply of Gardasil 9 syringes (0.5ML) with a firm fixed-price structure. The contract was awarded on January 23, 2026, with an ultimate completion date of January 26, 2026, and represents a non-set-aside competitive award. The place of performance is located in Conshohocken, Pennsylvania, where the vendor's corporate office is headquartered. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a $999.99 billion single-award IDC that runs through December 2031 and serves as the primary vehicle for delivering pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen, through its parent organization Cencora, maintains a substantial presence in federal pharmaceutical procurement, particularly with the Defense Logistics Agency and other military health systems. The Gardasil 9 vaccine supply under this delivery order supports critical immunization requirements for the Defense Health Agency and related military treatment facilities. As an established pharmaceutical distributor with demonstrated capability to fulfill federal medical supply needs through open competition, AmerisourceBergen leverages its comprehensive IDC vehicle to provide diverse pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains to support military healthcare operations worldwide.
Quick answers
Who was awarded contract SPE2DR26F3FU8?
SPE2DR26F3FU8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26F3FU8 worth?
The government has obligated $36,615 on SPE2DR26F3FU8.
Is contract SPE2DR26F3FU8 an order under another contract?
Yes. SPE2DR26F3FU8 is a delivery order under SPE2DR25D3017, an indefinite delivery contract.
Was contract SPE2DR26F3FU8 competed?
The extent of competition for SPE2DR26F3FU8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award